A Pandemic-Free Future: Building Better Preparedness Through Partnership

This panel discussion will explore how to make the 100 Days Mission a global reality. To do this, it will focus on the pivotal significance of preparedness and the necessary investments in Research, Development, and Manufacturing. It will also examine the central role of effective partnerships across the global health ‘ecosystem’ to establish a synchronized, rapid and equitable global response to future viral threats.

We will look to see how the world coalesces to overcome viral challenges. It is an opportunity to take a deeper look at the concept of a one-world vaccine library which could harness recent scientific advances, including immunogen design and prototype vaccines, with clinical data for major viral families. Undertaking and bolstering global research and development, with an equity-driven ambition, could potentially transform future global responses to emerging disease outbreaks.

We will elaborate on the imperative to establish global and geo-diversified partnerships to strengthen Pandemic Prevention, Preparedness, and Response (Pandemic PPR), including enhancing regional clinical trial and manufacturing ability. Additionally, to ensure a globally coordinated response, the discussion will also identify the distinct roles different stakeholders and sectors in the global health ecosystem, and beyond, will need to play to enable the Mission's success.

Ultimately, our panel of experts will delve into the various aspects of preparedness and partnerships necessary for the 100 Days Mission. Critically it will explore the essential investments that are required now, and not later, to ensure prompt execution of the 100 Days Mission – and the days thereafter – when the next viral threat emerges.